Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice

IntroductionSenescent cells (SCs) accumulate with age and play a causative role in age-related diseases, such as idiopathic pulmonary fibrosis (IPF). Clearance of SCs attenuates lung fibrogenesis and favors fibrosis resolution, suggesting that targeting of SCs is recognized as a promising therapeuti...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Wang, Fan Yang, Ying Liu, Meiting Peng, Lu Yu, Qinhui Hou, Yuan Liu, Zhenshun Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1506518/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849316074071261184
author Rui Wang
Fan Yang
Ying Liu
Meiting Peng
Lu Yu
Qinhui Hou
Yuan Liu
Zhenshun Cheng
Zhenshun Cheng
Zhenshun Cheng
author_facet Rui Wang
Fan Yang
Ying Liu
Meiting Peng
Lu Yu
Qinhui Hou
Yuan Liu
Zhenshun Cheng
Zhenshun Cheng
Zhenshun Cheng
author_sort Rui Wang
collection DOAJ
description IntroductionSenescent cells (SCs) accumulate with age and play a causative role in age-related diseases, such as idiopathic pulmonary fibrosis (IPF). Clearance of SCs attenuates lung fibrogenesis and favors fibrosis resolution, suggesting that targeting of SCs is recognized as a promising therapeutic approach for IPF. Isothiocyanates (ITCs) are natural compounds with anticancer and anti-aging properties, but their role in IPF remains unclear. The aim of our study to investigate whether benzyl isothiocyanate (BITC), a type of ITCs, can act as a senolytic agent thereby attenuating pulmonary fibrosis in aged mice.MethodsPrimary lung fibroblasts from IPF patients and controls were cultured and treated with various ITCs to identify potential senolytic agents. Senescence-associated β-galactosidase staining, Cell viability assays, Annexin V/PI double staining, Caspase 3 activity assay, Western blot analysis, and qPCR were performed to evaluate senescence markers, cell viability, and apoptosis-related proteins after BITC treatment of senescent IPF lung fibroblasts in vitro. HE staining, Masson staining, Hydroxyproline assay, and Western blot analysis were used to assess the pathological progress, collagen content of lung tissues, and fibrotic gene expression changes after BITC treatment in C57BL/6 aged mice.ResultsUsing senescent IPF fibroblasts, we screened and identified BITC as a potent senolytic drug. We show that BITC selectively induces apoptosis in senescent IPF fibroblasts by targeting AKT signal pathway. Intraperitoneal administration of BITC to an age-related lung fibrosis mouse model effectively depleted senescent lung fibroblasts and reversed persistent pulmonary fibrosis.DiscussionOur study reveals that BITC may be a promising therapeutic option for IPF and other age-related disease that progress with the accumulation of senescent fibroblasts.
format Article
id doaj-art-aef9dcc005b244c3b93e601ad17f138c
institution Kabale University
issn 1663-9812
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-aef9dcc005b244c3b93e601ad17f138c2025-08-20T03:51:58ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-05-011610.3389/fphar.2025.15065181506518Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged miceRui Wang0Fan Yang1Ying Liu2Meiting Peng3Lu Yu4Qinhui Hou5Yuan Liu6Zhenshun Cheng7Zhenshun Cheng8Zhenshun Cheng9Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaDepartment of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, ChinaWuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, ChinaHubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, ChinaIntroductionSenescent cells (SCs) accumulate with age and play a causative role in age-related diseases, such as idiopathic pulmonary fibrosis (IPF). Clearance of SCs attenuates lung fibrogenesis and favors fibrosis resolution, suggesting that targeting of SCs is recognized as a promising therapeutic approach for IPF. Isothiocyanates (ITCs) are natural compounds with anticancer and anti-aging properties, but their role in IPF remains unclear. The aim of our study to investigate whether benzyl isothiocyanate (BITC), a type of ITCs, can act as a senolytic agent thereby attenuating pulmonary fibrosis in aged mice.MethodsPrimary lung fibroblasts from IPF patients and controls were cultured and treated with various ITCs to identify potential senolytic agents. Senescence-associated β-galactosidase staining, Cell viability assays, Annexin V/PI double staining, Caspase 3 activity assay, Western blot analysis, and qPCR were performed to evaluate senescence markers, cell viability, and apoptosis-related proteins after BITC treatment of senescent IPF lung fibroblasts in vitro. HE staining, Masson staining, Hydroxyproline assay, and Western blot analysis were used to assess the pathological progress, collagen content of lung tissues, and fibrotic gene expression changes after BITC treatment in C57BL/6 aged mice.ResultsUsing senescent IPF fibroblasts, we screened and identified BITC as a potent senolytic drug. We show that BITC selectively induces apoptosis in senescent IPF fibroblasts by targeting AKT signal pathway. Intraperitoneal administration of BITC to an age-related lung fibrosis mouse model effectively depleted senescent lung fibroblasts and reversed persistent pulmonary fibrosis.DiscussionOur study reveals that BITC may be a promising therapeutic option for IPF and other age-related disease that progress with the accumulation of senescent fibroblasts.https://www.frontiersin.org/articles/10.3389/fphar.2025.1506518/fullidiopathic pulmonary fibrosiscellular senescencesenolysisbenzyl isothiocyanatefibroblasts
spellingShingle Rui Wang
Fan Yang
Ying Liu
Meiting Peng
Lu Yu
Qinhui Hou
Yuan Liu
Zhenshun Cheng
Zhenshun Cheng
Zhenshun Cheng
Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
Frontiers in Pharmacology
idiopathic pulmonary fibrosis
cellular senescence
senolysis
benzyl isothiocyanate
fibroblasts
title Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
title_full Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
title_fullStr Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
title_full_unstemmed Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
title_short Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
title_sort benzyl isothiocyanate provokes senolysis by targeting akt in senescent ipf fibroblasts and reverses persistent pulmonary fibrosis in aged mice
topic idiopathic pulmonary fibrosis
cellular senescence
senolysis
benzyl isothiocyanate
fibroblasts
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1506518/full
work_keys_str_mv AT ruiwang benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT fanyang benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT yingliu benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT meitingpeng benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT luyu benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT qinhuihou benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT yuanliu benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT zhenshuncheng benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT zhenshuncheng benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice
AT zhenshuncheng benzylisothiocyanateprovokessenolysisbytargetingaktinsenescentipffibroblastsandreversespersistentpulmonaryfibrosisinagedmice